These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11680924)

  • 1. [Symptomatic therapy of irritable bowel syndrome. Which drug for which symptoms?].
    Madisch A; Hotz J
    MMW Fortschr Med; 2001 Sep; 143(39):28-30. PubMed ID: 11680924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Irritable colon].
    Meier R; Meyer M; Degen L
    Ther Umsch; 1997 Nov; 54(11):654-60. PubMed ID: 9454369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of the irritable bowel syndrome and other functional bowel disorders.
    Mearin F
    Digestion; 2006; 73 Suppl 1():28-37. PubMed ID: 16498250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tegaserod: a novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome.
    Beglinger C
    Int J Clin Pract; 2002; 56(1):47-51. PubMed ID: 11831835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritable bowel syndrome.
    Ringel Y; Sperber AD; Drossman DA
    Annu Rev Med; 2001; 52():319-38. PubMed ID: 11160782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritable bowel syndrome: new approaches to its pharmacological management.
    Tougas G
    Can J Gastroenterol; 2001 Oct; 15 Suppl B():12B-13B. PubMed ID: 11694909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on irritable bowel syndrome.
    Bergmann KA
    Postgrad Med J; 2003 Dec; 79(938):715. PubMed ID: 14707260
    [No Abstract]   [Full Text] [Related]  

  • 8. Irritable bowel syndrome: an update on therapeutic modalities.
    Farhadi A; Bruninga K; Fields J; Keshavarzian A
    Expert Opin Investig Drugs; 2001 Jul; 10(7):1211-22. PubMed ID: 11772245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.
    Camilleri M; Ford AC
    Handb Exp Pharmacol; 2017; 239():75-113. PubMed ID: 27995391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proper patient counseling, recommended nutrition, specific medication. The basics of irritable bowel syndrome therapy].
    Fliegner-Baia M; Keller J; Layer P
    MMW Fortschr Med; 2002 Oct; 144(42):33-7. PubMed ID: 12533994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The irritable bowel syndrome: the current state of the problem].
    Babak OIa
    Lik Sprava; 2000; (3-4):6-11. PubMed ID: 10921248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.
    Horwitz BJ
    Health News; 2002 Oct; 8(10):1-2. PubMed ID: 12416480
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic therapy for the irritable bowel syndrome.
    Talley NJ
    Am J Gastroenterol; 2003 Apr; 98(4):750-8. PubMed ID: 12738451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Irritable bowel syndrome: current views on its pathogenesis, diagnosis and treatment].
    Sheptulin AA
    Klin Med (Mosk); 1997; 75(9):26-9. PubMed ID: 9432536
    [No Abstract]   [Full Text] [Related]  

  • 15. [New drug for irritable bowel syndrome].
    Hennemann A
    Med Monatsschr Pharm; 2001 Apr; 24(4):106-8. PubMed ID: 11338633
    [No Abstract]   [Full Text] [Related]  

  • 16. Contemporary thoughts on the treatment of irritable bowel syndrome.
    Giaquinta D
    Manag Care Interface; 2002 Aug; 15(8):19-20, 22. PubMed ID: 12229060
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.
    Olden K; DeGarmo RG; Jhingran P; Bagby B; Decker C; Markowitz M; Carter E; Bobbitt W; Dahdul A; DeCastro E; Gringeri L; Johanson J; Levinson L; Mula G; Poleynard G; Stoltz RR; Truesdale R; Young D;
    Am J Gastroenterol; 2002 Dec; 97(12):3139-46. PubMed ID: 12492201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alosetron for irritable bowel syndrome. Senior vice president of GlaxoSmithKline responds.
    Palmer JB
    BMJ; 2003 Jan; 326(7379):51. PubMed ID: 12511473
    [No Abstract]   [Full Text] [Related]  

  • 19. [Irritable bowel syndrome(IBS)].
    Kawasaki Y; Fujita K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):559-62. PubMed ID: 12877049
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diets in irritable bowel syndrome--what do they really achieve? Please no culinary sadism!].
    Stiefelhagen P
    MMW Fortschr Med; 2001 Nov; 143(46):18. PubMed ID: 11759593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.